Search

Brian S. Roberts

Examiner (ID: 403, Phone: (571)272-3095 , Office: P/2466 )

Most Active Art Unit
2466
Art Unit(s)
2619, 2662, 2616, 2419, 2466
Total Applications
1167
Issued Applications
966
Pending Applications
72
Abandoned Applications
158

Applications

Application numberTitle of the applicationFiling DateStatus
09/637681 Methods and compositions for diagnosis of hepatoma Aug 13, 2000 Abandoned
Array ( [id] => 7612640 [patent_doc_number] => 06903195 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Methods and compositions for detecting CDN apoptosis-modulating proteins' [patent_app_type] => utility [patent_app_number] => 09/633200 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 7560 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/903/06903195.pdf [firstpage_image] =>[orig_patent_app_number] => 09633200 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/633200
Methods and compositions for detecting CDN apoptosis-modulating proteins Aug 6, 2000 Issued
Array ( [id] => 1246230 [patent_doc_number] => 06677428 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Mammaglobin, a secreted mammary-specific breast cancer protein' [patent_app_type] => B1 [patent_app_number] => 09/509015 [patent_app_country] => US [patent_app_date] => 2000-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 12627 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677428.pdf [firstpage_image] =>[orig_patent_app_number] => 09509015 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/509015
Mammaglobin, a secreted mammary-specific breast cancer protein May 29, 2000 Issued
Array ( [id] => 6711002 [patent_doc_number] => 20030170751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Immunohistochemical assay for ras activity' [patent_app_type] => new [patent_app_number] => 09/569197 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6157 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170751.pdf [firstpage_image] =>[orig_patent_app_number] => 09569197 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/569197
Immunohistochemical assay for ras activity May 10, 2000 Abandoned
09/403075 MEKK1 PROTEINS AND FRAGMENTS THEREOF FOR USE IN REGULATING APOPTOSIS May 9, 2000 Abandoned
09/566441 Urokinase plasminogen activator receptor as a target for diagnosis of metastases May 7, 2000 Abandoned
Array ( [id] => 848891 [patent_doc_number] => 07381407 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-06-03 [patent_title] => 'Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen' [patent_app_type] => utility [patent_app_number] => 09/561462 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 16317 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381407.pdf [firstpage_image] =>[orig_patent_app_number] => 09561462 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/561462
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen Apr 27, 2000 Issued
Array ( [id] => 655191 [patent_doc_number] => 07109301 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-19 [patent_title] => 'Tenascin-C isoform as marker for neoplasias' [patent_app_type] => utility [patent_app_number] => 09/959373 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 2804 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109301.pdf [firstpage_image] =>[orig_patent_app_number] => 09959373 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/959373
Tenascin-C isoform as marker for neoplasias Apr 18, 2000 Issued
09/509779 SAG: SENSITIVE TO APOPTOSIS GENE Mar 28, 2000 Abandoned
Array ( [id] => 676444 [patent_doc_number] => 07087712 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-08 [patent_title] => 'Peptide for triggering an immune reaction against tumor cells' [patent_app_type] => utility [patent_app_number] => 10/019513 [patent_app_country] => US [patent_app_date] => 2000-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4128 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087712.pdf [firstpage_image] =>[orig_patent_app_number] => 10019513 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/019513
Peptide for triggering an immune reaction against tumor cells Mar 27, 2000 Issued
Array ( [id] => 1204627 [patent_doc_number] => 06716426 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Antitumor agents' [patent_app_type] => B1 [patent_app_number] => 09/536017 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 3857 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716426.pdf [firstpage_image] =>[orig_patent_app_number] => 09536017 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/536017
Antitumor agents Mar 26, 2000 Issued
09/402845 COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST TUMOR-RELATED ANTIGENS Mar 13, 2000 Abandoned
Array ( [id] => 6740729 [patent_doc_number] => 20030158098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Colon specific gene and protein' [patent_app_type] => new [patent_app_number] => 09/525041 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14582 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158098.pdf [firstpage_image] =>[orig_patent_app_number] => 09525041 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/525041
Colon specific gene and protein Mar 13, 2000 Issued
Array ( [id] => 1334776 [patent_doc_number] => 06596849 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules' [patent_app_type] => B1 [patent_app_number] => 09/520255 [patent_app_country] => US [patent_app_date] => 2000-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 38 [patent_no_of_words] => 17615 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596849.pdf [firstpage_image] =>[orig_patent_app_number] => 09520255 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/520255
Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules Mar 6, 2000 Issued
Array ( [id] => 1224616 [patent_doc_number] => 06699980 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/514768 [patent_app_country] => US [patent_app_date] => 2000-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 30 [patent_no_of_words] => 20524 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699980.pdf [firstpage_image] =>[orig_patent_app_number] => 09514768 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/514768
Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof Feb 27, 2000 Issued
09/512435 Treatment regimen for prostate cancer Feb 24, 2000 Abandoned
Array ( [id] => 5801469 [patent_doc_number] => 20020009755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'ALTERNATIVE SPLICING OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 MRNA IN PROSTATE CANCER' [patent_app_type] => new [patent_app_number] => 09/465802 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9839 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009755.pdf [firstpage_image] =>[orig_patent_app_number] => 09465802 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/465802
ALTERNATIVE SPLICING OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 MRNA IN PROSTATE CANCER Dec 16, 1999 Abandoned
Array ( [id] => 1501518 [patent_doc_number] => 06486300 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Human nm23-like protein' [patent_app_type] => B1 [patent_app_number] => 09/460532 [patent_app_country] => US [patent_app_date] => 1999-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17927 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486300.pdf [firstpage_image] =>[orig_patent_app_number] => 09460532 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/460532
Human nm23-like protein Dec 12, 1999 Issued
09/454595 METHODS OF IDENTIFYING POTENTIALLY THERAPEUTICALLY EFFECTIVE ANTINEOPLASTIC AGENTS WITH VIABLE CULTURED CELLS HAVING AN INTACT CELL MEMBRANE AND PRODUCT BT SAME Dec 6, 1999 Abandoned
Array ( [id] => 742010 [patent_doc_number] => 07030232 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-18 [patent_title] => 'E25A protein, methods for producing and use thereof' [patent_app_type] => utility [patent_app_number] => 09/451214 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14894 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030232.pdf [firstpage_image] =>[orig_patent_app_number] => 09451214 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/451214
E25A protein, methods for producing and use thereof Nov 28, 1999 Issued
Menu